Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients

Journal of Nuclear Medicine

Volumn 51, Issue 2, 2010, Pages 176-182

  Uyl De Groot, Carin A ^a,b   Senft, Asaf ^b   De Bree, Remco ^b   Leemans, C René ^b   Hoekstra, Otto S ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F FDG PET; Cost; Cost effectiveness; CT; Distant metastases; Head and neck cancer; Screening

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; WHOLE BODY AUTORADIOGRAPHY; WHOLE BODY CT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DIAGNOSTIC ERRORS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 75749103381     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.067371     Document Type: Article

References (19)

1. de Bree R, Leemans CR. New developments for optimal management of head and neck cancer. Onkologie. 2004;27:339-342.
2. Brouwer J, de Bree R, Hoekstra OS, et al. Screening for distant metastases in patients with head and neck cancer: is chest CT sufficient? Laryngoscope. 2005;115:1808-1812.
3. de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope. 2000;110:397-400.
4. Black RJ, Gluckman JL, Shumrick DA. Screening for distant metastases in head and neck cancer patients. Aust N Z J Surg. 1984;54:527-530.
5. Jäckel MC, Rausch H. Distant metastasis of squamous epithelial carcinomas of the upper aerodigestive tract: the effect of clinical tumor parameters and course of illness [in German]. HNO. 1999;47:38-44.
6. Leibel SA, Scott CB, Mohiuddin M, et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results from an analysis of the RTOG head and neck database. Int J Radiat Oncol Biol Phys. 1991;21:549-556.
7. Merino OR, Linberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1977;40:145-151.
8. Léon X, Quer M, Orus C, del Prado Venegas M, Lopez M. Distant metastases in head and neck cancer patients who achieved local-regional control. Head Neck. 2000;22:680-686.
9. Leemans CR, Tiwari R, Nauta JJP, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer. 1993;71:452-456.
10. Loh KS, Brown DH, Baker JT, Gilbert RW, Gullane PJ, Irish JC. A rational approach to pulmonary screening in newly diagnosed head and neck cancer. Head Neck. 2005;27:990-994.
11. Senft A, de Bree R, Hoekstra OS, et al. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial. Radiat Oncol. 2008;87:221-229.
12. 18F-FDG PET and extended-field multi-detector row CT. Neuroradiology. 2008; 50:969-979.
13. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Toronto, Ontario: Oxford University Press; 2005.
14. Oostenbrink J, Bouwmans C, Koopmanschap M, Rutten F. Manual for Cost Research, Methods and Standard Cost Prices for Economic Evaluation in Health Care. Diemen, The Netherlands: College voor zorgverzekeringen; 2004.
15. Verboom P, van Tinteren H, Hoekstra OS, et al. Cost-effectiveness of FDG-PET in staging non-small cell lung-cancer: the PLUS study. Eur J Nucl Med Mol Imaging. 2003;11:1444-1449.
16. Farmacotherapeutisch Kompas. Available at: http://www.fk.cvz.nl. Accessed November 23, 2009.
17. Levendag PC, Nijdam WM, van Agthoven M. Uyl- de Groot CA. Chemotherapy and high-dose-rate brachytherapy in the management of advanced cancers of the nasopharynx: clinical impact of high technology - is it worth the cost? Brachytherapy. 2002;1:11-20.
18. Braaksma M, van Agthoven M, Nijdam W, Uyl-de Groot CA, Levendag PC. Costs of treatment intensification for head and neck cancer: concomitant chemoradiation randomised for radioprotection with amifostine. Eur J Cancer. 2005;41:2102-2111.
19. Gourin CG, Watts TL, Williams HT, Patel VS, Bilodeau PA, Coleman TA. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer. Laryngoscope. 2008;118:671-675.